David Donabedian is Vice President, Venture Investments, where he is responsible for the investment strategy for AbbVie Biotech Ventures Inc. (ABVI). In this role he oversees the identification, evaluation and execution of equity investments in emerging biotech companies.
Prior to joining AbbVie, Dr. Donabedian was Senior Vice President, Locust Walk Partners, where he led strategic transactions and engagement for biotech and pharmaceutical companies. He has over 17 years of experience in the life sciences industry and has held a number of senior leadership roles related to business development, fundraising, strategy and research, including Vice President, Global New Deal Strategy & Development at GlaxoSmithKline’s Centre of Excellence for External Drug Discovery; Vice President of Business Development for Surface Logix; and Senior Manager in Accenture’s Strategic Services Consulting Group. Dr. Donabedian began his career as a research scientist with Dow Chemical and Boston Scientific.
He holds a bachelor’s degree in chemistry from St. Anselm College, a Ph.D. in polymer chemistry from the University of Massachusetts, Lowell and an MBA from the University of North Carolina at Chapel Hill.